Review: Joint statement on inappropriate prescribing and dispensing of medications during the COVID-19 pandemic

Home/Review: Joint statement on inappropriate prescribing and dispensing of medications during the COVID-19 pandemic

Review: Joint statement on inappropriate prescribing and dispensing of medications during the COVID-19 pandemic

Review: Joint statement on inappropriate prescribing and dispensing of medications during the COVID-19 pandemic

This Joint Statement of the National Association of Boards of Pharmacy (NAPB) and Federation of State Medical Boards (FASB) notes that physicians, pharmacists, pharmacies and hospitals have an ethical duty to put the needs of patients first, and this includes observing strict prescribing guidelines of chloroquine, hydroxychloroquine and azithromycin.

The statement notes that there are reports that some physicians are inappropriately prescribing medications to prevent or treat COVID-19 for themselves or their family members and that some pharmacies and hospitals may be stockpiling these medications in anticipation of future demand. On March 28, the Food and Drug Administration issued an Emergency Use Authorization (EUA) for use of oral formulations of chloroquine phosphate and hydroxychloroquine sulfate. The EUA allows these medications to be prescribed by doctors for hospitalized adult and adolescent patients “for whom a clinical trial is not available, or participation is not feasible.” Physicians should avoid prescribing for themselves or their family members, and pharmacies and hospitals should refrain from inappropriately stockpiling these medications.

|2020-04-02T16:28:16-04:00April 2nd, 2020|COVID-19 Literature|Comments Off on Review: Joint statement on inappropriate prescribing and dispensing of medications during the COVID-19 pandemic

About the Author: Seema Mohapatra

Seema Mohapatra
Seema Mohapatra is an Associate Professor of Law and Dean's Fellow at the Indiana University Robert H. McKinney School of Law, She teaches Introduction to Health Care Law and Policy, Genetics and the Law, Torts, and Bioethics and the Law. Seema Mohapatra is an expert in the areas of health care law, public health law, bioethics, torts, and international health and family law. Her research interests include the intersection of biosciences and the law, assisted reproduction and surrogacy, international family and health law, health care disparities in the United States, and informed consent. Her work has been published in several journals, including the Wake Forest Law Review, Colorado Law Review, Brooklyn Law Review, and the Harvard Journal of Law & Policy. Professor Mohapatra currently teaches Torts, Introduction to Health Care Law, Bioethics, and Genetics and the Law. She has authored articles and book chapters on topics such as insurance coverage of infertility and assisted reproduction, genetics and health privacy, international surrogacy laws, and equity in healthcare coverage. Professor Mohapatra regularly presents her research nationally and internationally at legal and medical conferences and symposia. Prior to teaching, Professor Mohapatra practiced health law in Chicago at Sidley & Austin and Foley & Lardner. She earned a J.D. degree from Northwestern University School of Law and has a master’s degree in Public Health with a concentration in Chronic Disease Epidemiology from Yale University. She earned a bachelor of arts in Natural Sciences (with a minor in Women's Studies) from Johns Hopkins University.

Get Involved with Indiana CTSI